Immunovative Therapies Ltd (ITL)

Welcome to Immunovative Therapies, Ltd. (ITL). Allow us to introduce you to our Company. We are an international biopharmaceutical company headquartered in Jerusalem, Israel. We are a spin-out from Hadassah Hebrew University Medical Center and have received start-up financial support from the Israel Office of the Chief Scientist. We have operations in: Israel; Phoenix, Arizona USA; and, Bangkok, Thailand. We use knowledge of how the immune system works to protect us from disease and translate this knowledge into products that harness the power of the immune system to treat cancer and infectious diseases.

SPECIALITY INFORMATION

patients


Treatment strategy designed to use the power of the human immune system to kill tumors and prevent their recurrence.
No requirement for a matched donor or chemotherapy/radiation conditioning prior to treatment.
Innovative technology – proven and non-toxic.
read more

Healthcare professionals


Therapeutic anti-tumor vaccine developed from core break-through technology called the "Mirror Effect™“ which opens a pathway to treating patients with metastatic cancer that have failed all available therapy options.
Elicits a GVT-like mechanism without the GVHD toxicity.
read more

Investors


Privately-held Israeli biopharmaceutical company spin out from Hadassah-Hebrew University Medical Center with headquarters in Jerusalem.

Over 200 individual private shareholders and grant support from the Israel Office of the Chief Scientist.
read more